Litigation Details for Indivior Inc. v. Aveva Drug Delivery Systems, Inc. (S.D. Fla. 2019)
✉ Email this page to a colleague
Indivior Inc. v. Aveva Drug Delivery Systems, Inc. (S.D. Fla. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-03-22 |
| Court | District Court, S.D. Florida | Date Terminated | 2019-11-18 |
| Cause | 35:0271 Patent Infringement | Assigned To | Roy Kalman Altman |
| Jury Demand | Defendant | Referred To | Patrick M. Hunt |
| Patents | 8,017,150; 8,603,514; 9,687,454; 9,931,305 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Indivior Inc. v. Aveva Drug Delivery Systems, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Indivior Inc. v. Aveva Drug Delivery Systems, Inc. (S.D. Fla. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-03-22 | 1 | expiration of U.S. Patent Nos. 8,017,150 (“the ’150 patent”); 8,603,514 (“the ’514 patent”); 9,687,454 (… (“the ’454 patent”); and 9,931,305 (“the ’305 patent”) (collectively, the “patents-in-suit”). …454 patent, and Plaintiff Indivior is an exclusive licensee of the ’454 patent. The ’454 patent, entitled…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United… THE PATENTS-IN-SUIT 21. Plaintiff Aquestive is the lawful owner of the ’150 patent, and | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
